Log in with your email address username.

×

Important notice

doctorportal Learning is on the move as we will be launching a new website very shortly. If you would like to sign up to dp Learning now to register for CPD learning or to use our CPD tracker, please email support@doctorportal.com.au so we can assist you. If you are already signed up to doctorportal Learning, your login will work in the new site so you can continue to enrol for learning, complete an online module, or access your CPD tracker report.

To access and/or sign up for other resources such as Jobs Board, Bookshop or InSight+, please go to www.mja.com.au, or click the relevant menu item and you will be redirected.

All other doctorportal services, such as Find A Doctor, are no longer available.

[Correspondence] Percutaneous coronary intervention for stable angina in ORBITA

We applaud ORBITA1 by Rasha Al-Lamee and colleagues as a well executed first placebo-controlled trial of the incremental impact of percutaneous coronary intervention (PCI) on exercise time (ET) in stable angina. However, given the study’s importance, we were surprised by the statistics. By use of an unpaired T test, the authors compared change in ET between treatment groups and found no difference (16·6 s, 95% CI −8·9 to 42·0, p=0·20). However, in parallel randomised trials, mixed effects models such as ANCOVA are indicated because they are more precise than the unpaired T test, correct for baseline imbalances that predispose to regression to the mean, and confer increased statistical power to detect small but clinically meaningful differences.

email